Soligenix SNGX
NASDAQ SNGX
$0.36 +0.01 (+4.23%)
As of: Oct 22, 2026 · 11:18 AM EDT

Soligenix (SNGX) Long-Term Deferred Tax (2017)

Updated

Soligenix (SNGX) reported Long-Term Deferred Tax of $14 million for Q4 2017.

Analysis

Soligenix (SNGX) Long-Term Deferred Tax (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,175.39 Bn 1,143.98 Bn 19.71 Bn
2 Johnson & Johnson 639.10 Bn 557.63 Bn 17.26 Bn
3 AbbVie 502.70 Bn 475.81 Bn 12.70 Bn
4 Merck 376.68 Bn 331.05 Bn 12.21 Bn
5 Novartis Ag 304.33 Bn 268.32 Bn 11.24 Bn
6 Astrazeneca 267.75 Bn 241.43 Bn 12.86 Bn
7 Amgen 242.34 Bn 197.73 Bn 7.24 Bn
8 Gilead Sciences 193.67 Bn 167.87 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Soligenix 5.82 Mn -28.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 14.00 Mn
API Access

Soligenix Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=SNGX&period=max&api_key=YOUR_API_KEY